Keywords: IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; TDLU; terminal ductal lobular unit; Breast; Estrogens; Androgens; Tissue; Cancerous; Benign;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AR; androgen receptor; BPA; bisphenol A; DCIS; ductal in situ carcinoma; EDC; endocrine disrupting compounds; E2; estradiol; ER; estrogen receptor; ERα; estrogen receptor alpha; G; genistein; GV; genistein + vinclozolin; PND; postnatal day; PR; progest
Keywords: DCIS; Treatment; Axillary staging; Variation; Screening
Keywords: Breast; Cancer; DCIS; In situ; Screening; Symptomatic
Keywords: Ductal carcinoma in situ; DCIS; Tamoxifen;
Keywords: Ductal carcinoma in situ; Breast cancer; DCIS; DIN; Radiation therapy
Keywords: Breast; DCIS; nomogram; prediction; recurrence;
Keywords: Breast cancer; Lumpectomy; Surgical margin; Intraoperative evaluation; Imaging; Polarization; BCS; breast conserving surgery; RCM; reflectance confocal microscopy; OCM; optical coherence microscopy; ASCO; American Society of Clinical Oncologists; CAP; Col
Keywords: Breast screening; DCIS; Pathology; Radiology; Outcomes; Practice variation
Keywords: ADH; atypical ductal hyperplasia; AH; atypical hyperplasia; ALH; atypical lobular hyperplasia; BBD; benign breast disease; BI-RADS; Breast Imaging Reporting and Data System; BSIP; benign solitary intraductal papilloma; CCL; columnar cell lesion; CNB; core
Keywords: lncRNA; long/large noncoding RNA; Xist; X-inactive specific transcript; mESC; mouse embryonic stem cell; Evf2; embryonic ventral forebrain 2; Six3os; sine oculis-related homeobox 3 homolog, opposite strand; Dlx1as; distal-less homeobox 1, antisense; EGO;
Keywords: Sentinel node biopsy; Frozen section; Breast cancer; MSFS; Multiple Step-section Frozen Section; ALND; axillary lymph node dissection; SLN; sentinel lymph node; WLE; wide local excision; DCIS; ductal carcinoma in-situ; RT-PCR; Reverse Transcriptase Polyme
Keywords: Wide local excision; Breast cancer; Questionnaire; Margin; Ductal carcinoma in situ; DCIS;
Keywords: DCIS; Molecular subtypes; Ethnicity; Basal-like;
Keywords: Locally advanced breast cancer; Primary systemic therapy; Neoadjuvant chemotherapy; Disseminated tumor cells; Bone marrow; CR; complete clinical response; CTC; circulating tumor cells; DCIS; ductal carcinoma in situ; DFS; disease-free survival; DTC; disse
Keywords: VVA; vulvovaginal atrophy; SERM; selective estrogen receptor modulator; NDA; new drug application; FDA; Food and Drug Administration; NSABP; National Surgical Adjuvant Breast & Bowel Project; STAR; Study of Tamoxifen and Raloxifene; ER; estrogen receptor;
Keywords: SERM; selective estrogen receptor modulator; BRCAT; breast cancer risk assessment tool; IBIS; International Breast Cancer Intervention Study Model; NSAID; non-steroidal anti-inflammatory; DCIS; ductal carcinoma in situ; OVX; ovariectomy; Tamoxifen; Postpa
Keywords: Breast cancer; DCIS; ductal carcinoma in situ;
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy
Keywords: DCIS; Radiation; Outcomes; Breast preservation;
Development of a New Monochrome Multiplex qPCR Method for Relative Telomere Length Measurement in Cancer
Keywords: scg; single-copy genes; mcs; multiple-copy sequences; T; telomere quantity; S; scg quantity; M; mcs quantity; DNA; deoxyribonucleic acid; PCR; polymerase chain reaction; MMQPCR; monochrome multiplex quantitative PCR; EDTA; ethylenediaminetetraacetic acid;
MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer
Keywords: Breast cancer; miRNA; miRNA cluster; miRNA co-expression; Microarray; BC; breast cancer; DCIS; ductal carcinoma in-situ; ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; ER; estrogen receptor; GSEA; gene set enrichment analysis; IDC;
Prise en charge des carcinomes mammaires in situ : surtraitement ? Peut-on faire moins ?
Keywords: Cancer canalaire in situ; CCIS; Traitement; Chirurgie; Radiothérapie; Récidive locale; Surtraitement; Sous traitement; Ductal carcinoma in situ; DCIS; Treatment; Surgery; Radiotherapy; Local recurrence; Overtreatment; Undertreatment;
Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis
Keywords: ALP; alkaline phosphatase; BI-RADS; Breast Imaging Reporting and Data System; BMP2; bone morphogenetic protein 2; BSP; bone sialoprotein; CA1; carbonic anhydrase I; COX2; cyclooxygenase-2; DCIS; ductal carcinoma in situ; EMT; epithelial-mesenchymal transi
Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation
Keywords: DA; dominant active; DN; dominant negative; DCIS; ductal carcinoma in situ; ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; ERK; extracellular-signal regulated kinase; ER; estrogen receptor; GAP; GTPase activating protein; GFP; green
Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer
Keywords: ALDH1; aldehyde dehydrogenase isoform 1; BC; breast cancer; BMI; body mass index; DCIS; ductal carcinoma in situ; ERα; estrogen receptor alpha; MiRNA; microRNA; SOX; SRY-related HMG box; TNM; tumor, node and metastasis; MicroRNA-140-3p; MicroRNA; Breast
Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies
Keywords: Circulating tumor cells (CTCs); Circulating tumor microemboli (CTM); CTC clusters; Metastasis; Epithelial to mesenchymal transition (EMT); CTC; circulating tumor cells; CTM; circulating tumor microemboli; VEGF-A; vascular endothelial growth factor A; DCIS
Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation
Keywords: Breast Cancer; c-KIT; Epigenetics; DNA methylation; Immunohistochemistry; ADH; Atypical ductal hyperplasia; BCA; Bicinchoninic acid; CML; Chronic myelogenous leukemia; CK5/6; Cytokeratin 5/6; CK903; Cytokeratin 903; DCIS; Ductal Carcinoma in situ; ER; Est
Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States
Keywords: Boost; Breast conservation; DCIS; Hypofractionation; Radiation therapy;
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
Keywords: BC; breast Cancer; ER; estrogen Receptor; PgR,PR; progesteron receptor; HER-2; human epidermal growth factor receptor 2; TNBC; triple negative breast cancer; ncRNA; non coding RNA; CpG(s); cytosine-phosphate-guanine dinucleotide(s); 5-me-C; 5-methyl-cytos
The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential
Keywords: APC/C; anaphase-promoting complex/cyclosome; ASF1; antisilencing function 1; BRAF35; BRCA2-associated factor 35; BRCA2; breast cancer 2 protein; CAF-1; chromatin assembly factor 1; CR; cysteine rich; DCIS; ductal carcinoma in situ; DNMT3B; DNA methyltrans
Achieving clear margins. Directed shaving using MarginProbe, as compared to a full cavity shave approach
Keywords: BCS; breast conserving surgery; IDC; invasive ductal carcinoma; DCIS; ductal carcinoma in situ; ER; estrogen receptor; PR; progesteron receptor; HER2; human epidermal growth factor receptor 2;
The First Case of HER2+ Invasive Ductal Carcinoma Arising From a Breast Hamartoma and Literature Review
Keywords: Breast cancer; Her2; Hamartoma; DCIS; ductal carcinoma in situ; LCIS; Lobular carcinoma in situ; IDC; invasive ductal carcinoma; ILC; invasive lobular carcinoma;
Evaluation of percutaneous vacuum assisted intact specimen breast biopsy device for ultrasound visualized breast lesions: Upstage rates and long term follow-up for high risk lesions and DCIS
Keywords: High risk lesion; Atypical hyperplasia; Lobular neoplasia; Upstage rate; Ultrasound guided breast biopsy; Intact specimen; DCIS; Breast cancer;
MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion
Keywords: MRI; Surveillance; Mammographically dense breasts; Breast cancer; Atypical hyperplasia; Cancer detection rate; DCIS; BIRADS; Mammographically occult;
Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy
Keywords: B3 lesion; Lesion of uncertain malignant potential; Papillary lesion; Atypia; PPV for malignancy; Breast cancer; DCIS;
Sentinel lymph node biopsy in low risk settings
Keywords: SLNB; Low risk; Mastectomy; DCIS; Prophylactic mastectomy;
Flat Epithelial Atypia: Upgrade Rates and Risk-Stratification Approach to Support Informed Decision Making
Keywords: ADH; atypical ductal hyperplasia; ALH; atypical lobular hyperplasia; DCIS; ductal carcinoma in situ; FEA; flat epithelial atypia; LCIS; lobular carcinoma in situ;
Research papersThe breast lesion excision system (BLES) under stereotactic guidance cannot be used as a therapeutic tool in the excision of small areas of microcalcifications in the breast
Keywords: ADH; atypical ductal hyperplasia; BLES; breast lesion excision system; CNB; core needle biopsy; DCIS; ductal carcinoma in situ; IDC; invasive ductal carcinoma; LCIS; lobular carcinoma in situ; RF; radiofrequency; US; ultrasound; VABB; vacuum-assisted brea
Original articleHistologic factors predicting invasion in patients with ductal carcinoma in situ (DCIS) in the preoperative core biopsy
Keywords: Breast cancer; DCIS; Core biopsy; Predictive factors; Upstaging;
Impact of the Addition of Digital Breast Tomosynthesis (DBT) to Standard 2D Digital Screening Mammography on the Rates of Patient Recall, Cancer Detection, and Recommendations for Short-term Follow-up
Keywords: DBT; tomosynthesis; BIRADS 3; short-term follow-up; DCIS;
Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ
Keywords: Adjuvant treatment; DCIS; Invasive carcinoma; Metastases; SLNB;
Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement
Keywords: Invasive lobular breast cancer; Preoperative MRI; DCIS; Background parenchymal enhancement; Repeated surgery;
Research papersDigital breast tomosynthesis versus full-field digital mammography-Which modality provides more accurate prediction of margin status in specimen radiography?
Keywords: DBT; digital breast tomosynthesis; FFDM; full-field digital mammography; SR; specimen Radiography; IDC/NST; invasive ductal carcinoma/carcinoma of non-special type; DCIS; ductal carcinoma in situ; BCS; breast conserving surgery; R1/R2; Reader 1/Reader 2;
Research articleComparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study
Keywords: BI-RADS; Breast Imaging-Reporting and Data System; BPE; background parenchymal enhancement; CI; confidence interval; CEDM; contrast enhanced digital mammography; DCIS; ductal carcinoma in situ; MIP; maximum intensity projection; MRI; magnetic resonance im
Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer
Keywords: Vitamin D; Stem cells; Mammosphere; Breast cancer; OCT4; 1α,25(OH)2D3; 1α,25-dihydroxyvitamin D3; TNBC; triple negative breast cancer; MFE; mammosphere forming efficiency; NFκB; nuclear factor kappa-light-chain-enhancer of activated B cells; DCIS; duct
Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy
Keywords: DCIS; Disease free survival; Dose fractionation; Radiation therapy; Tamoxifen;
Study protocol: A randomized controlled trial of a comprehensive breast cancer treatment patient decision tool (iCanDecide)
Keywords: Breast cancer; Decision tool; Decision-making; Health communication; DCIS; Ductal Carcinoma In Situ; GEE; Generalized Estimating Equation; RCT; Randomized Controlled Trial; SEER; Surveillance, Epidemiology, and End Results Program;
Original contributionTumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ
Keywords: DCIS; Invasive ductal carcinoma with a predominant intraductal component (DICPIC); Logistic regression analysis; Predicting invasion within DCIS; Tumor thickness;
MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction
Keywords: 5-FU; 5-fluorouracil; 5NP; five negative; AC; adjuvant chemotherapy; AGO; Argonaute; BC; breast cancer; CA153; cancer antigen 153; CEA; Carcinoembryonic antigen; DCIS; ductal carcinoma in situ; DFS; disease-free survival; DGCR8; DiGeorge Syndrome Critical